药效评价Identification of an orally active opioid receptor-like 1 (ORL1) receptor antagonist 4-{3-[(2R)-2,3-dihydroxypropyl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-1-[(1S,3S,4R)-spiro[bicyclo[2.2.1]heptane-2,1'-cyclopropan]-3-ylmethyl]piperidine as clinical
期刊:Journal of medicinal chemistry发表年份:2009作者:Atsushi Satoh; Takeshi Sagara; Hiroki Sakoh; Masaya Hashimoto; Hiroshi Nakashima; Tetsuya Kato; Yasuhiro Goto; Sayaka Mizutani; Tomoko Azuma-Kanoh; Takeshi Tani; Shoki Okuda; Osamu Okamoto; Satoshi Ozaki; Yoshikazu Iwasawa; Hisashi Ohta; Hiroshi Kawa